Financial Ratios

TEJNAKSH HEALTHCARE LTD.

NSE : NABSE : 539428ISIN CODE : INE030T01027Industry : Hospital & Healthcare ServicesHouse : Private
BSE21.64-0.17 (-0.78 %)
PREV CLOSE ( ) 21.81
OPEN PRICE ( ) 22.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5293
TODAY'S LOW / HIGH ( )21.50 22.20
52 WK LOW / HIGH ( ) 20.530.5
NSE
This Company is not listed in NSE
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)0.891.362.481.971.89
   CEPS(Rs)1.291.071.531.291.24
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)11.2120.6219.2516.7614.78
   Tax Rate(%)25.4629.6925.2722.6227.70
Margin Ratios
   Core EBITDA Margin(%)44.4042.7653.0941.8930.95
   EBIT Margin(%)38.0535.2047.4336.5330.06
   Pre Tax Margin(%)29.5826.7641.5230.2723.14
   PAT Margin (%)22.0518.8131.0323.4216.73
   Cash Profit Margin (%)31.7829.5938.3230.5721.83
Performance Ratios
   ROA(%)6.054.729.598.328.42
   ROE(%)8.296.8113.7712.5113.69
   ROCE(%)11.399.5715.8714.1416.58
   Asset Turnover(x)0.270.250.310.360.50
   Sales/Fixed Asset(x)0.320.350.490.500.65
   Working Capital/Sales(x)1.972.063.8811.402.68
Efficiency Ratios
   Fixed Capital/Sales(x)3.142.892.042.011.53
   Receivable days38.8343.5318.4319.1411.92
   Inventory Days17.3320.5120.3115.9912.66
   Payable days111.9391.1680.98172.47160.07
Valuation Parameters
   PER(x)25.9625.3633.9736.8919.01
   PCE(x)18.0132.2555.0228.2614.57
   Price/Book(x)2.073.348.754.342.44
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)5.8210.0821.659.153.72
   EV/Core EBITDA(x)12.1921.9339.5620.9510.59
   EV/EBIT(x)15.3028.6445.6425.0512.38
   EV/CE(x)1.742.706.133.281.76
   M Cap / Sales5.729.5421.088.643.18
Growth Ratio
   Net Sales Growth(%)12.08-9.64-5.14-25.57-17.63
   Core EBITDA Growth(%)16.51-24.0918.83-7.51-19.81
   EBIT Growth(%)21.17-32.9423.16-9.53-23.49
   PAT Growth(%)31.35-45.2225.684.19-28.55
   EPS Growth(%)-34.32-45.2225.674.20-28.55
Financial Stability Ratios
   Total Debt/Equity(x)0.210.310.360.290.48
   Current Ratio(x)4.223.852.121.543.95
   Quick Ratio(x)3.883.581.861.243.72
   Interest Cover(x)4.494.178.025.834.35
   Total Debt/Mcap(x)0.100.090.040.070.20

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.